1 / 4

POLYCLONAL ANTIBODY MARKET ANALYSIS, 2020 - 2027

Polyclonal antibodies are a heterogeneous mix of antibodies derived from the immune response of multiple B-cells, in which each one recognizes a different epitope on the same antigen. Polyclonal antibodies are composed of a mixture of antibodies that represent the natural immune response to an antigen.

akshay925
Télécharger la présentation

POLYCLONAL ANTIBODY MARKET ANALYSIS, 2020 - 2027

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Polyclonal Antibody Market, by Type (Primary Antibody Polyclonal Antibody Market, by Type (Primary Antibody and Secondary Antibody), by Application (Academic and Secondary Antibody), by Application (Academic Research and Commercial), and by Region (North Research and Commercial), and by Region (North America, Latin America, Europe, Asia Pacific, Middle America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027 Analysis, 2020 - 2027 Polyclonal antibodies are a heterogeneous mix of antibodies derived from the immune response of multiple B-cells, in which each one recognizes a different epitope on the same antigen. Polyclonal antibodies are composed of a mixture of antibodies that represent the natural immune response to an antigen. Polyclonal antibodies are used in general research applications. Moreover, increasing incidence of cancer across the globe is expected to boost the market growth. According to an article published by Cancer Research UK in 2015, 55,122 new cases of breast cancer were registered in 2015. In the U.K., breast cancer was the most common cancer, accounting for 15% of all new cancer cases in 2015. The global polyclonal antibody market is estimated to be valued at US$ 943.6 million and is expected to exhibit a CAGR of 5.2% 5.2% during the forecast period (2020-2027). US$ 943.6 million in 2020 (2020-2027). 2020 Get PDF Brochure Of This Research Report @ : Get PDF Brochure Of This Research Report @ : https://www.coherentmarketinsights.com/insight/request-pdf/4347 https://www.coherentmarketinsights.com/insight/request-pdf/4347

  2. Rising cases of infectious diseases are expected to propel growth of the global polyclonal Rising cases of infectious diseases are expected to propel growth of the global polyclonal antibody market. antibody market. Rising incidence of infectious diseases such as Ebola virus worldwide, especially in under- developed countries, is expected to drive the market growth during the forecast period. For instance, according to an article published by the World Health Organization (WHO) in February 2020, the outbreak of Ebola virus in West Africa was the largest outbreak during 2014-2016 and it still continues in various countries. The ongoing development of polyclonal antibodies in North America is expected to drive the The ongoing development of polyclonal antibodies in North America is expected to drive the market growth. market growth. North America is expected to hold dominant position in the global polyclonal antibody market owing to ongoing research and development in the region. For instance, in August 2018, SAB Biotherapeutics, Inc. (SAB), a clinical-stage biopharmaceutical company, announced that its anti- Ebola immunotherapy, SAB-139, offers100% protection against a lethal dose of the Ebola virus in an animal study published in The Journal of Infectious Diseases. The study was conducted by the National Interagency Confederation for Biological Research in collaboration with the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) and the Naval Medical Research Center (NMRC). Global Polyclonal Antibody Market – Impact of Coronavirus (COVID-19) Pandemic Global Polyclonal Antibody Market – Impact of Coronavirus (COVID-19) Pandemic The coronavirus (COVID-19) pandemic and resulting lockdowns in various countries across the globe have impacted the financial status of businesses in all sectors. The private healthcare is one such sector which has been impacted significantly by the COVID-19 pandemic. Lockdowns in various countries have placed an economic burden on the healthcare sector. Moreover, the coronavirus pandemic has hampered the development, production, and supply of drugs and other healthcare products, and affected growth of healthcare businesses of various companies across the globe.

  3. As a result, the impact of the COVID-19 pandemic is expected to limit growth of the global polyclonal antibody market during the forecast period. Research Methodology Research Methodology Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include: Primary Research (Trade Surveys and Experts Interviews) Primary Research (Trade Surveys and Experts Interviews) • Desk Research Desk Research • Proprietor Data Analytics Model Proprietor Data Analytics Model • In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings. Key Players Key Players Major players operating in the global polyclonal antibody market are Abcam plc, GenScript, global polyclonal antibody market are Abcam plc, GenScript, Merck KGaA., IgY Immune Technologies & Life Sciences Inc., Thermo Fisher Scientific Inc., Merck KGaA., IgY Immune Technologies & Life Sciences Inc., Thermo Fisher Scientific Inc., Takara Bio Inc., Genway Biotech, Inc., Geno Technology Inc., DC Biosciences Ltd., Good Takara Bio Inc., Genway Biotech, Inc., Geno Technology Inc., DC Biosciences Ltd., Good Biotech Corp, Rockland Immunochemicals, Inc., EpiGentek Group Inc., Innovagen AB., and Biotech Corp, Rockland Immunochemicals, Inc., EpiGentek Group Inc., Innovagen AB., and GeneTex, Inc. among others. GeneTex, Inc. among others.

  4. Request Sample Copy of Research Report @ : Request Sample Copy of Research Report @ : https://www.coherentmarketinsights.com/insight/request-sample/4347 https://www.coherentmarketinsights.com/insight/request-sample/4347 About Coherent Market Insights About Coherent Market Insights Coherent Market Insights is a prominent market research and consulting firm offering action- ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us Contact Us Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: sales@coherentmarketinsights.com Email: sales@coherentmarketinsights.com

More Related